Skip to content

Evaluation of CyclaPlex Implant for Correction of First Inter Metatarsal Angle in Subjects Suffering From Hallux Valgus Deformity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02727595
Enrollment
5
Registered
2016-04-04
Start date
2016-04-30
Completion date
2017-09-30
Last updated
2016-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus

Brief summary

The purpose of the study is to evaluate safety, tolerability and performance of the CyclaPlex implant, a button and suture type implant device and instruments for the correction of the first inter metatarsal angle in subjects suffering from Hallux Valgus deformity.

Interventions

DEVICECyclaPlex Implant

Button and suture type implant that will be implanted between the first and second metatarsal

Sponsors

Cycla Orthopedics Ltd.
CollaboratorINDUSTRY
Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Weight less than 100 kilos * IMA greater than 12 degrees * IMA less than 7 degrees

Exclusion criteria

* Diabetics * Known osteoporosis * Known allergy or hypersensitivity to metals * Gout or any systemic inflammatory arthropathy

Design outcomes

Primary

MeasureTime frameDescription
IMA ReductionOne yearThe IMA angle is measured pre-op and post-op on x-ray images using internal software. The IMA at end of study should be less than 10 degrees or a reduction of more than 5 degrees.

Secondary

MeasureTime frameDescription
American Orthopedic Foot and Ankle Society (AOFAS) ScoreOne yearGeneral improvement as assessed by AOFAS Hallux Scale metatarsophalangeal interphalangeal scale score

Countries

Israel

Contacts

Primary ContactRafi Herzog, BSc
rherzog@netvision.net.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026